BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4101700)

  • 21. [Tumorous prostatic diseases. I. Prostatic adenoma--genesis, clinical aspects, therapy].
    Reichelt H
    Z Allgemeinmed; 1974 May; 50(15):688-93. PubMed ID: 4137484
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical experiences with phyto-therapy of benign prostatic hypertrophy].
    Bauer KM
    Med Welt; 1980 Aug; 31(34):1211-4. PubMed ID: 6159518
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical study of a phytosterol extract of Prunus arborea and 3 amino acids: glycine, alanine and glutamic acid].
    Cuervo Blanco E; Francia Bengoechea A; Fraile Gómez B
    Arch Esp Urol; 1978; 31(1):97-8. PubMed ID: 697415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical evaluation of Prosta-caps].
    Weiser
    Dtsch Med J; 1972 Feb; 23(2):155-6. PubMed ID: 4111749
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical application of "PPC" to prostatic hypertrophy and others].
    Sugiura H; Shimaya M
    Hinyokika Kiyo; 1969 Jun; 15(6):450-3. PubMed ID: 4185864
    [No Abstract]   [Full Text] [Related]  

  • 26. [Tadenan in the treatment of prostatic adenoma. Anatomo-clinical study].
    Bongi G
    Minerva Urol; 1972; 24(4):129-39. PubMed ID: 4141048
    [No Abstract]   [Full Text] [Related]  

  • 27. [Regression of the symptoms of prostatic adenomas. Results of 6 months' conservative treatment using ERU capsules].
    Maar K
    Fortschr Med; 1987 Jan; 105(1):18-20. PubMed ID: 2435642
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of prostamol-Uno on oxidative and local immune status in patients with benign prostatic hyperplasia and chronic prostatitis].
    Seregin SP; Bratchikov OI; Konoplia AI; Shestakov SG; Dolzhenkov SD; Novikov AV; Shatokhin MN; Kotov AV
    Urologiia; 2002; (4):14-6. PubMed ID: 12357892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Standardized extract of Pygeum africanum in the treatment of benign prostatic hypertrophy. Controlled clinical study versus placebo].
    Bassi P; Artibani W; De Luca V; Zattoni F; Lembo A
    Minerva Urol Nefrol; 1987; 39(1):45-50. PubMed ID: 2441479
    [No Abstract]   [Full Text] [Related]  

  • 30. [Conservative therapy of prostatic hypertrophy with Fink Prosta capsules].
    Lütgen T
    Dtsch Med J; 1970 May; 21(9):625-6. PubMed ID: 4098219
    [No Abstract]   [Full Text] [Related]  

  • 31. [Limits of conservative treatment of prostatic adenoma and possibilities of its prevention].
    Thiel KH
    Med Welt; 1976 Jul; 27(29):1405-8. PubMed ID: 60685
    [No Abstract]   [Full Text] [Related]  

  • 32. [Drug treatment options in prostatic hyperplasia].
    Hauri D
    Praxis (Bern 1994); 1997 Sep; 86(38):1463-6. PubMed ID: 9381047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serrated dwarfpalm in the therapy of benign prostate hypertrophy. Portrait of a plant medicine].
    Mühlbauer S
    Fortschr Med Monogr; 1991; 51():1-9, 11. PubMed ID: 1720111
    [No Abstract]   [Full Text] [Related]  

  • 34. Preoperative mini-heparin, prostatectomy and clinical pulmonary thromboembolism.
    Miller EV; Butz GW
    Int Surg; 1981; 66(2):155-6. PubMed ID: 6168599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cytomorphologic studies of benign prostate hyperplasia treated with extract radicis urticae (ERU). Preliminary results].
    Ziegler H
    Fortschr Med; 1982 Oct; 100(39):1832-4. PubMed ID: 6185399
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical study of Eviprostat for the treatment of benign prostatic hyperplasia].
    Song Y; Li NC; Wang XF; Ma LL; Wan B; Hong BF; Na YQ
    Zhonghua Nan Ke Xue; 2005 Sep; 11(9):674-6. PubMed ID: 16209208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drug treatment of prostatic hypertrophy].
    Sökeland J; Bressel M
    Dtsch Med Wochenschr; 1966 Nov; 91(44):1982-4. PubMed ID: 4163463
    [No Abstract]   [Full Text] [Related]  

  • 38. Botulinum-A toxin: an exciting new treatment option for prostatic disease.
    Thomas CA; Guercini F; Chuang YC; Chancellor MB
    Int J Clin Pract Suppl; 2006 Dec; (151):33-7. PubMed ID: 17169009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A so-called open prostatectomy (author's transl)].
    Zoedler D
    Urologe A; 1974 May; 13(3):105-6. PubMed ID: 4135808
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparison of operative approach for prostatectomy, 1948 and 1968.
    Bennett AH; Harrison JH
    Surg Gynecol Obstet; 1969 May; 128(5):969-74. PubMed ID: 4180879
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.